HRA Raising Game To Promote UK OTC Daily Contraceptive, Hopes US Switch Will Follow
Executive Summary
HBW Insight speaks to HRA Pharma CEO David Wright about the company's recent UK Rx-to-OTC contraceptive pill switch, it's signifcance for the global women's health category and the implications for a similar switch the company is pursuing in the US.